Home Trak Plus EASI Event Recorder System
510(k) K982090
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK982090 | Date26 Jan 1999 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Paceart Home Trak Plus Easi Event Recorder System
- 510(k) Number
- FDA Product Code
- DXH
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2920
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Home Trak Plus EASI Event Recorder System is a patient-activated ambulatory cardiac event monitor designed to record infrequent and elusive heart arrhythmias. It employs a five-electrode recording system to derive a 12-lead electrocardiogram (EASI system) and transmits recorded data via telephone to a central analysis center for review. This device is classified as a Class II transmitter and receiver for electrocardiographic purposes, enabling remote monitoring of cardiac events outside clinical settings.
The system consists of a looping cardiac event recorder worn by the patient and a central-station program for data reception and analysis. It is intended for single-use or reusable configurations as specified by the manufacturer, with no explicit mention of MRI safety or sterility requirements in the provided data. The device is authorized under FDA 510(k) clearance (K982090) and falls under the regulatory category of DXH, with no indication of third-party involvement. Storage and handling instructions are not detailed in the specifications.
Other devices from Paceart, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Home Trak Plus EASI Event Recorder System used for?
The Home Trak Plus EASI Event Recorder System is designed to detect and record infrequent or elusive cardiac arrhythmias in patients outside clinical settings. It uses a five-electrode system to generate a 12-lead electrocardiogram (EASI system), allowing for detailed cardiac monitoring. The recorded data is then transmitted via telephone to a central analysis center for review by healthcare professionals, enabling remote monitoring of cardiac events.
How is the Home Trak Plus EASI Event Recorder System supplied?
The system consists of two main components: a looping cardiac event recorder worn by the patient and a central-station program for receiving and analyzing the transmitted data. The patient recorder is the primary device used for capturing cardiac events, while the central-station program handles data processing. The manufacturer specifies that the system can be configured for either single-use or reusable applications, though specific handling or sterility instructions are not detailed in the provided data.
Is the Home Trak Plus EASI Event Recorder System reusable or single-use?
The Home Trak Plus EASI Event Recorder System can be used in either single-use or reusable configurations, as determined by the manufacturer’s specifications. The decision depends on clinical protocols, facility policies, and cost-effectiveness considerations. Since no explicit sterility requirements or MRI safety information is provided, users should follow manufacturer guidelines to ensure proper handling and reuse if applicable.
How does the Home Trak Plus EASI Event Recorder System transmit recorded data?
The system transmits recorded cardiac event data via telephone lines to a central analysis center. This remote transmission capability allows healthcare providers to review the 12-lead ECG recordings without requiring the patient to visit a clinical facility. The central-station program processes and analyzes the transmitted data for further medical evaluation.
What regulatory pathway was followed for the Home Trak Plus EASI Event Recorder System?
The Home Trak Plus EASI Event Recorder System was cleared through the FDA’s 510(k) pathway, specifically under the traditional review process. It was submitted to the Cardiovascular (CV) Advisory Committee and classified as substantially equivalent to a predicate device. The clearance number is K982090, and the device falls under the product code DXH for transmitters and receivers used in electrocardiographic purposes.